Expertise in
1
conditions

Zengqing R. Guo

No. 420 Fuma Road, 
Fuzhou, CN 
Expertise in
1
conditions
No. 420 Fuma Road, 
Fuzhou, CN 

Overview

Zengqing Guo practices practicing medicine in Fuzhou, China.

Guo is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Malnutrition, Stomach Cancer, Gastrointestinal Perforation, Colorectal Cancer, and Endoscopy.

They are actively involved in clinical research, co-authoring 76 peer reviewed articles and participating in 2 clinical trials.

Locations

No. 420 Fuma Road, Fuzhou, 350014, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of AK104 Plus Oxaliplatin and Capecitabine (XELOX) Versus Placebo Plus XELOX as First-line Treatment for Locally Advanced Unresectable or G/GEJ Adenocarcinoma
A Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of AK104 Plus Oxaliplatin and Capecitabine (XELOX) Versus Placebo Plus XELOX as First-line Treatment for Locally Advanced Unresectable or G/GEJ Adenocarcinoma
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Drug: AK104
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

76 Total Publications

Age-dependent prognostic value of biological age for metastasis and survival in gastrointestinal cancer.
Age-dependent prognostic value of biological age for metastasis and survival in gastrointestinal cancer.
Journal: Scientific reports
Published: November 11, 2025

Frequently Asked Questions about Zengqing R. Guo

Is Zengqing R. Guo a top-rated expert for Malnutrition?

MediFind is an objective health platform that identifies experts based on real-world data. Zengqing R. Guo is classified as an Advanced expert for Malnutrition, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Zengqing R. Guo participate in research or clinical trials?

Yes. Zengqing R. Guo has published 76 articles and abstracts on conditions like Malnutrition. You can view a list of Zengqing R. Guo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Guo's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile